Gene · 23308
Papers2,855
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,855
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Soluble immune checkpoint factors reveal high-risk osteosarcoma subtypes and enable early metastasis prediction. | Front Immunol | 2025 | 40963634 | PubTator, text mining | PubMed |
| Unraveling cooperative and competitive interactions within protein triplets in the human interactome. | Sci Rep | 2025 | 40954205 | PubTator, text mining | PubMed |
| Unlocking new frontiers: novel immune targets for next-generation cancer immunotherapy. | Korean J Clin Oncol | 2025 | 40916400 | PubTator, text mining | PubMed |
| Development of an in vitro method to assess the immunogenicity of biologics in the prevention of infectious diseases. | Immunol Res | 2025 | 40900356 | PubTator, text mining | PubMed |
| The Role of Cutaneous B-Cells in Hidradenitis Suppurativa: From Preclinical Evidence to Novel Targeted Therapies. | Exp Dermatol | 2025 | 40898716 | PubTator, text mining | PubMed |
| Tissue-Resident T Cells That Promote Humoral Immunity: Emerging From the Shadow of T Follicular Helper Cells. | Immunol Rev | 2025 | 40890948 | PubTator, text mining | PubMed |
| IgM and IgG1 B cell receptors differentially affect B cell fates and dictate the pathogenesis of mature B cell lymphomas. | Sci Adv | 2025 | 40880486 | PubTator, text mining | PubMed |
| The HDAC inhibitor romidepsin renders liver cancer vulnerable to RTK targeting and immunologically active. | Nat Commun | 2025 | 40855049 | PubTator, text mining | PubMed |
| Loss of ICOSL expression in the progression to cervical carcinoma. | Proc Natl Acad Sci U S A | 2025 | 40854131 | PubTator, text mining | PubMed |
| Identification of Plasma Biomarkers for B7 Family Members Associated With Primary Sjögren's Syndrome. | Immun Inflamm Dis | 2025 | 40844039 | PubTator, text mining | PubMed |
| The distinct landscape of tumor immune microenvironment in homologous recombination deficient cancers. | Biomark Res | 2025 | 40830526 | PubTator, text mining | PubMed |
| Evaluation value of SIRI combined with baseline indicators in immune reconstitution of PLWH after ART: A cohort study. | Medicine (Baltimore) | 2025 | 40826786 | PubTator, text mining | PubMed |
| Checkpoint immunotherapy is associated with preferential activation of tumor antigen-specific CD4+ T cells in MDS. | Blood Neoplasia | 2025 | 40809194 | PubTator, text mining | PubMed |
| Modulating the serine metabolism in human differentiated astrocytes: an integrated multi omics approach. | Front Cell Neurosci | 2025 | 40761926 | PubTator, text mining | PubMed |
| Development of a Mitochondrial Permeability Transition-Driven Necrosis-Related Prognostic Signature in Cervical Cancer: Integrating Bulk Transcriptomic and Single-Cell Data. | Cancer Med | 2025 | 40747615 | PubTator, text mining | PubMed |
Comprehensive Characterization of the Immune Microenvironment Based on Nested Resampling Machine Learning Framework Identifies TRAF3 Interacting Protein 3 as a Promising Regulator to Improve the Resistance to Immunotherapy in Glioma. | Adv Sci (Weinh) | 2025 | 40714831 | PubTator, text mining | PubMed |
| Targeted degradation of sICOSL reverses cytotoxic T cells dysfunction. | Exp Hematol Oncol | 2025 | 40708008 | PubTator, text mining | PubMed |
| Spectral cytometry of rheumatoid arthritis patients implicates myeloid dendritic cells and granular HLA-DR+CD15+CD16+ cells in pro-inflammatory antigen presentation. | Front Immunol | 2025 | 40703515 | PubTator, text mining | PubMed |
| B-cell extracellular vesicle biomarkers for detection of antibody-mediated rejection in lung transplantation. | JTCVS Tech | 2025 | 40641786 | PubTator, text mining | PubMed |
| Gemcitabine-loaded ICOS-Fc decorated nanosponges: A new chemo immunotherapy combination against pancreatic cancer. | Int J Pharm | 2025 | 40543732 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23308/papers?page=4